These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30272313)

  • 1. ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer.
    Xu GL; Shen J; Xu YH; Wang WS; Ni CF
    Mol Med Rep; 2018 Dec; 18(6):5087-5094. PubMed ID: 30272313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
    Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
    Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
    Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
    Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
    [No Abstract]   [Full Text] [Related]  

  • 4. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375.
    Xu N; Qiao L; Yin L; Li H
    J BUON; 2019; 24(6):2273-2279. PubMed ID: 31983094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1.
    Wang X; Qiu H; Tang R; Song H; Pan H; Feng Z; Chen L
    Oncol Rep; 2018 Jun; 39(6):2635-2643. PubMed ID: 29693179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells.
    Lee KJ; Kim NH; Kim HS; Kim Y; Lee JJ; Kim JH; Cho HY; Jeong SY; Park ST
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241228
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
    Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
    EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
    Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ROR1-AS1 enhances colorectal cancer metastasis by targeting miR-375.
    Wang FZ; Zhang MQ; Zhang L; Zhang MC
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6899-6905. PubMed ID: 31486489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.
    Wang W; Zheng W; Zhang L; Li K
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment acidity modulates ROR1 to promote epithelial-mesenchymal transition and hepatocarcinoma metastasis.
    Meng X; Xu Y; Ning X
    J Cell Sci; 2021 Apr; 134(7):. PubMed ID: 33648935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
    Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
    Genes Cells; 2024 Jun; 29(6):503-511. PubMed ID: 38531660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Li N; Wang C; Zhang P; You S
    Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
    Han L; Zan Y; Huang C; Zhang S
    Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
    Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
    Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
    Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
    Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.